Federation des caisses Desjardins du Quebec’s Calliditas Therapeutics AB American Depositary Shares CALT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-3,985
Closed -$83.7K 2590
2024
Q1
$83.7K Buy
3,985
+1,500
+60% +$33.4K ﹤0.01% 1283
2023
Q4
$64K Hold
2,485
﹤0.01% 1237
2023
Q3
$45.4K Buy
2,485
+450
+22% +$7.79K ﹤0.01% 1336
2023
Q2
$32.2K Buy
2,035
+500
+33% +$10.6K ﹤0.01% 1448
2023
Q1
$36.8K Buy
1,535
+500
+48% +$9.99K ﹤0.01% 1412
2022
Q4
$17.6K Hold
1,035
﹤0.01% 1716
2022
Q3
$15.7K Hold
1,035
﹤0.01% 1803
2022
Q2
$18.4K Hold
1,035
﹤0.01% 1789
2022
Q1
$19.8K Hold
1,035
﹤0.01% 1829
2021
Q4
$25.6K Hold
1,035
﹤0.01% 1764
2021
Q3
$22.4K Buy
1,035
+625
+152% +$17.1K ﹤0.01% 1821
2021
Q2
$12.1K Buy
+410
New +$11.7K ﹤0.01% 2010

Other funds holding CALT

Federation des caisses Desjardins du Quebec's CALT Position: Q2 2024 in Review

Federation des caisses Desjardins du Quebec sold out of Calliditas Therapeutics AB American Depositary Shares (CALT) in Q2 2024, closing a stake of 3,985 shares — an estimated $83.7K sold.

Federation des caisses Desjardins du Quebec first reported a position in CALT in Q2 2021 and held it in 12 quarters. The position peaked at $83.7K in Q1 2024. 18 funds tracked by Wall St. Rank hold CALT as of Q2 2024.

  • Federation des caisses Desjardins du Quebec reported no remaining Calliditas Therapeutics AB American Depositary Shares position as of Q2 2024 after selling out during the quarter.
  • Federation des caisses Desjardins du Quebec sold 3,985 Calliditas Therapeutics AB American Depositary Shares shares in Q2 2024, an estimated $83.7K.
  • Federation des caisses Desjardins du Quebec first reported a position in Calliditas Therapeutics AB American Depositary Shares in Q2 2021 and held it in 12 quarters.
  • Federation des caisses Desjardins du Quebec's Calliditas Therapeutics AB American Depositary Shares position peaked at $83.7K in Q1 2024.
  • 18 funds tracked by Wall St. Rank held Calliditas Therapeutics AB American Depositary Shares as of Q2 2024.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q2 2024, filed 14 Aug 2024.